Clinical Trials Logo

Neoplasm Metastasis clinical trials

View clinical trials related to Neoplasm Metastasis.

Filter by:

NCT ID: NCT04941872 Completed - Clinical trials for Tumor, Solid, FAPI, PET/CT, Metastasis

Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer

Start date: June 18, 2021
Phase: N/A
Study type: Interventional

To evaluate the potential usefulness of 68Ga-DOTA-2P(FAPI)2 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer, compared with 68Ga-DOTA-FAPI-46 PET/CT.

NCT ID: NCT04925557 Completed - Clinical trials for Secondary-progressive Multiple Sclerosis

Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis

Start date: November 13, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

To assess the efficacy of Mayzent on microglia pathology in patients with active SPMS, as compared to the active control group of MS patients treated with the Ocrevus, as measured by changes in microglial activation in the lesional and non-lesional NAWM and NAGM and in the peri-plaque area of chronic lesions in the brain.

NCT ID: NCT04912128 Completed - Clinical trials for Stereotactic Body Radiation Therapy

Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC

AnloSBRT
Start date: January 15, 2017
Phase:
Study type: Observational

The purpose of this study is to determine whether stereotactic radiosurgery combination with Anlotinib could improve the efficacy and outcomes for non-small cell lung cancer with limited brain metastases.

NCT ID: NCT04896099 Completed - Metastatic Cancer Clinical Trials

Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial

ES4-UIC
Start date: June 7, 2021
Phase:
Study type: Observational

The purpose of the study is to assess the supportive care needs of patients enrolled in a therapeutic trial for metastatic cancer.

NCT ID: NCT04870645 Completed - Clinical trials for Malignant Solid Neoplasm

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

Start date: March 30, 2021
Phase: N/A
Study type: Interventional

This clinical trial studies the different types of investigational imaging techniques called sequences during magnetic resonance imaging (MRI) of the head before and after radiation therapy in patients with cancer that has spread to the brain (intracranial metastases). This clinical trial also compares these new techniques with standard MRI imaging to see if sequences provide better images. Diagnostic procedures, such as MRI, may help find and diagnose solid organ cancer and find out how far the disease has spread.

NCT ID: NCT04845308 Completed - Alveolar Cleft Clinical Trials

Radiographic Evaluation of Secondary Alveolar Bone Grafting in Patients With Alveolar Cleft

SABG
Start date: April 1, 2021
Phase:
Study type: Observational

Study about the comparison of post-operative results of secondary alveolar grafts according to two age groups: early secondary (4 to 7 years) versus late secondary (8 to 11 years) using a recently proposed score based on post-operative 3D CT analysis. Comparison of the initial results of the graft in the two groups, with a reference 2D score and evaluation of the concordance between the results found with this score and those of the 3D score. Finally, comparison of graft bone densities and nasal floor level (using 3D visualization) on post-operative TDMs in the 2 groups. The aim of this study is to determine the optimal age for grafting using three-dimensional CT assessment.

NCT ID: NCT04832672 Completed - Clinical trials for The Optimal Sequence of Radiotherapy and Systematic Tyrosine Kinase Inhibitors in Treating Brain Metastases

Sequence of Radiation and Targeted Therapy in Brain Metastases

Start date: October 1, 2010
Phase:
Study type: Observational

The investigators conducted a single institutional, retrospective cohort study to demonstrate the appropriate treatment strategy of upfront intracranial radiotherapy or upfront targeted therapy in patients with brain metastases, including an assessment of its feasibility and toxicity.

NCT ID: NCT04821518 Completed - Stroke Clinical Trials

The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After Stroke

Start date: November 15, 2020
Phase:
Study type: Observational [Patient Registry]

The aim of the present study was to quantitatively assess the risk factors that may affect the re-occurrence of a CVD event and the use of a commercially available mobile application Samsung Health for the assessment of parameters of exercise tolerance and the ECG M-Trace Base II application for the assessment of cardiological parameters.

NCT ID: NCT04812509 Completed - Bone Metastases Clinical Trials

Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors

Start date: March 20, 2020
Phase: Phase 3
Study type: Interventional

A multi-center, randomized, double-blind, parallel controlled Phase III clinical study to evaluate the clinical efficacy and safety of MW032 and Xgeva® in patients with bone metastases from solid tumors.

NCT ID: NCT04792567 Completed - Clinical trials for Secondary Progressive Multiple Sclerosis

Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

AMA-VACC
Start date: April 19, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study was to understand whether participants could mount an immune response to SARS-CoV-2 modRNA vaccines administered either during continuous siponimod treatment or during a treatment break versus while on treatment with first-line DMTS or no current MS treatment..